Benzinga | Nov 16, 2020 06:32AM EST

Cerevel Therapeutics Hldg Q3 EPS $(4.34) Up From $(5.16) YoY

Cerevel Therapeutics Hldg (NASDAQ:CERE) reported quarterly losses of $(4.34) per share. This is a 15.89 percent increase over losses of $(5.16) per share from the same period last year.